Joinn Laboratories

Joinn Laboratories, China’s leading non-clinical contract research organization (CRO), announced on Monday its revenue rose 15.1% to 575 million yuan in the third quarter.

FAST NEWS: Joinn Lab profit slumps on falling lab monkey prices

The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Monday its revenue rose 15.1% to 575 million yuan ($78.6 million) in the third quarter,…
6127.HK 603127.SHG

Joinn profits slide as lab monkey build-up backfires

The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals Key Takeaways: Joinn…
6127.HK 603127.SHG

Recent Articles

RELATED ARTICLES

  1. Joinn Laboratories, China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million to 419 million yuan for 2023, down 61.1% to 71.1% from the previous year.
    FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low
    6127.HK 603127.SHG
  2. FAST NEWS: Joinn Lab profit slumps on falling lab monkey prices
    6127.HK 603127.SHG
  3. CIMC Vehicles heads for Hong Kong exit ramp via share buyback
    1839.HK 301039.SHE
  4. East Buy ditches tuition to become pure e-commerce player
    1797.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva